| (Values in U.S. Thousands) | Jan, 2025 | Oct, 2024 | Jul, 2024 | Jan, 2025 | Oct, 2024 |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | -2,409 | -181 | -317 | 0 | 0 |
| Net Income Growth | -1,230.20% | +42.84% | unch | unch | unch |
Onco-Innovations Limited (ONCO.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Onco-Innovations Ltd is a preclinical-stage biotechnology company. The company is engaged in the business of the commercialization of cancer treatments and therapies.
Fiscal Year End Date: 04/30